Cargando…

Adverse Prognostic Impact of Diagnostic Ureterorenoscopy in a Subset of Patients with High-Risk Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy

SIMPLE SUMMARY: Although adverse oncological effects of ureterorenoscopy (URS) on disease progression have been of concern, no study has demonstrated such effects in patients with upper tract urothelial carcinoma (UTUC) undergoing radical nephroureterectomy (RNU). The present retrospective study inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yonese, Ichiro, Ito, Masaya, Waseda, Yuma, Kobayashi, Shuichiro, Toide, Masahiro, Takazawa, Ryoji, Koga, Fumitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406558/ https://www.ncbi.nlm.nih.gov/pubmed/36010955 http://dx.doi.org/10.3390/cancers14163962

Ejemplares similares

Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma
por: Sung, Hyun Hwan, et al.
Publicado: (2015)

Prognostic significance of sarcopenia in upper tract urothelial carcinoma patients treated with radical nephroureterectomy
por: Fukushima, Hiroshi, et al.
Publicado: (2016)

Biopsy with Ureterorenoscopy Before Radical Nephroureterectomy is Associated with Increased Intravesical Recurrence in Urothelial Cancer Located in the Kidney
por: Culpan, Meftun, et al.
Publicado: (2022)

Controlling Nutritional Status (CONUT) Score and Sarcopenia as Mutually Independent Prognostic Biomarkers in Advanced Urothelial Carcinoma
por: Une, Minami, et al.
Publicado: (2022)

The role of lymphadenectomy at the time of radical nephroureterectomy for upper tract urothelial carcinoma
por: Goltzman, Michael E., et al.
Publicado: (2020)

Comparison of Radical Nephroureterectomy and Partial Ureterectomy for the Treatment of Upper Tract Urothelial Carcinoma
por: Zhang, Jianzhong, et al.
Publicado: (2018)

Transperitoneal radical nephroureterectomy is associated with worse disease progression than retroperitoneal radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma
por: Kim, Tae Heon, et al.
Publicado: (2019)

Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in Taiwan
por: Chen, I-Hsuan Alan, et al.
Publicado: (2022)

Prognostic Value of Comorbidity for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy
por: Ke, Hung-Lung, et al.
Publicado: (2022)

Preoperative Underweight Patients with Upper Tract Urothelial Carcinoma Survive Less after Radical Nephroureterectomy
por: Kang, Ho Won, et al.
Publicado: (2015)

Predictors of Intravesical Recurrence After Radical Nephroureterectomy and Prognosis in Patients with Upper Tract Urothelial Carcinoma
por: Li, Yun-Ren, et al.
Publicado: (2020)

Oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma: a literature review
por: Grob, Gabrielle, et al.
Publicado: (2023)

Laparoscopic nephroureterectomy for upper tract urothelial carcinoma – Update
por: Lin, Victor C., et al.
Publicado: (2016)

External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma
por: Ku, J H, et al.
Publicado: (2013)

Prognostic impact of preoperative statin use after radical nephroureterectomy for upper urinary tract urothelial carcinoma
por: Lim, Ju Hyun, et al.
Publicado: (2015)

The Characteristics of Recurrent Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy without Bladder Cuff Excision
por: Kang, Minyong, et al.
Publicado: (2015)

Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy
por: Lee, Kwang Suk, et al.
Publicado: (2015)

The Influence of Tumor Size on Oncologic Outcomes for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy
por: Su, Xiaohong, et al.
Publicado: (2016)

Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma is Independently Associated with Intravesical Recurrence after Radical Nephroureterectomy
por: Liu, Pei, et al.
Publicado: (2016)

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy
por: Zhong, Wenlong, et al.
Publicado: (2017)

Robot-assisted radical nephroureterectomy with extended template lymphadenectomy for upper tract urothelial carcinoma: An outcome analysis
por: Tamhankar, Ashwin Sunil, et al.
Publicado: (2018)

Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer
por: Chung, Younsoo, et al.
Publicado: (2020)

Impact of cachexia on oncologic outcomes of sarcopenic patients with upper tract urothelial carcinoma after radical nephroureterectomy
por: Chen, Hao-Wei, et al.
Publicado: (2021)

Retrograde pyelography before radical nephroureterectomy for upper tract urothelial carcinoma is associated with intravesical tumor recurrence
por: Ko, Young Hwii, et al.
Publicado: (2020)

Pyuria as an independent predictor of intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial carcinoma
por: Lee, Jooho, et al.
Publicado: (2023)

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma
por: Horiguchi, Hirotaka, et al.
Publicado: (2018)

AB87. Evaluating the impact of preoperative anemia on the prognosis of upper tract urothelial carcinoma following radical nephroureterectomy
por: Xing, Yunchao, et al.
Publicado: (2014)

The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence
por: Lee, Hsiang-Ying, et al.
Publicado: (2018)

Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy
por: Shan, Hongli, et al.
Publicado: (2020)

Endoscopic management versus radical nephroureterectomy for localized upper tract urothelial carcinoma in a high endemic region
por: Chen, Yung-Tai, et al.
Publicado: (2021)

Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma
por: Kim, Tae Heon, et al.
Publicado: (2021)

Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
por: Ryoo, Hyunsoo, et al.
Publicado: (2021)

Body Composition Parameters May Be Prognostic Factors in Upper Urinary Tract Urothelial Carcinoma Treated by Radical Nephroureterectomy
por: Pan, Yulong, et al.
Publicado: (2021)

Survival and risk factors among upper tract urothelial carcinoma patients after radical nephroureterectomy in Northeast China
por: Gao, Jianing, et al.
Publicado: (2022)

Prognostic value of the endothelial activation and stress index in patients with upper tract urothelial cancer undergoing radical nephroureterectomy
por: Gu, Jin Seok, et al.
Publicado: (2022)

Correlation between the timing of diagnostic ureteroscopy for upper tract urothelial cancer and intravesical recurrence after radical nephroureterectomy
por: Luo, Zhenkai, et al.
Publicado: (2023)

Surgical techniques and oncological outcomes of pure transperitoneal laparoscopic radical nephroureterectomy for upper urinary tract urothelial carcinoma
por: Yuan, Changwei, et al.
Publicado: (2023)

Prognostic value of the systemic immune-inflammation index in patients with upper tract urothelial carcinoma after radical nephroureterectomy
por: Luo, Zhenkai, et al.
Publicado: (2023)

Is Segmental Ureterectomy Associated with Inferior Survival for Localized Upper-Tract Urothelial Carcinoma of the Ureter Compared to Radical Nephroureterectomy?
por: Paciotti, Marco, et al.
Publicado: (2023)

A Case of Metastatic Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome-Associated Renal Cell Carcinoma Treated with a Sequence of Axitinib and Nivolumab Following Cytoreductive Nephrectomy
por: Yonese, Ichiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_60u15j12f4pasc1k51l7jm6r8b